Theratechnologies (TH) Shares Up 4.8%
Shares of Theratechnologies Inc (TSE:TH) shot up 4.8% during trading on Thursday . The stock traded as high as C$7.71 and last traded at C$7.71. 132,944 shares traded hands during mid-day trading, an increase of 21% from the average session volume of 110,294 shares. The stock had previously closed at C$7.36.
Several brokerages have recently commented on TH. National Bank Financial raised their target price on Theratechnologies from C$9.25 to C$9.75 and gave the stock an “outperform” rating in a research report on Thursday, October 5th. Scotiabank decreased their target price on Theratechnologies from C$10.00 to C$9.25 and set an “outperform” rating for the company in a research report on Friday, October 6th.
The firm has a market cap of $596.70, a price-to-earnings ratio of -40.58 and a beta of 0.80.
ILLEGAL ACTIVITY WARNING: This story was first posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.watchlistnews.com/theratechnologies-th-shares-up-4-8/1794573.html.
Theratechnologies Company Profile
Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with Analyst Ratings Network's FREE daily email newsletter.